#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalopathy neonatal Cutaneous T-cell lymphoma stage II Dementia Alzheimer's type Cutaneous T-cell lymphoma Ocular lymphoma Burkitt's lymphoma refractory B-cell lymphoma refractory Blastic plasmacytoid dendritic cell neoplasia Cardiac arrest Gastrointestinal disorder Malignant neoplasm of choroid Diffuse large B-cell lymphoma recurrent Non-Hodgkin's lymphoma refractory Epstein-Barr virus associated lymphoproliferative disorder Pyoderma gangrenosum More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Basic Information Rhabdoid tumour – Basic Information Niemann-Pick disease Hairy cell leukaemia recurrent – Diagnostics Aicardi-Goutieres syndrome – Life with Disease Primary mediastinal large B-cell lymphoma – Basic Information Mantle cell lymphoma stage III – Trials in Disease Hereditary angioedema – Diagnostics Systemic mastocytosis – Life with Disease Nodal marginal zone B-cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ipn01194 Efmoroctocog Alfa Linezolid Estradiol Valerate Trimethoprim Favezelimab SPY002 GEN1078 Petrelintide Letrozole NVG-2089 Moxifloxacin Hydrochloride GRNA-001 Etripamil Bi 685509 [18F]Fapi-74 Bcmacp03 Valproate Semisodium Sar444656 Olodaterol More therapies…

    Learn about Your Condition

    Metastases to peritoneum Type 1 diabetes mellitus Affective disorder Chronic kidney disease Cystic fibrosis Androgenetic alopecia Mucopolysaccharidosis I Encephalitis Japanese B Epiphysiolysis Peritoneal abscess Non-small cell lung cancer Papillary thyroid cancer Laparotomy Colon cancer stage II Bladder cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Levetiracetam
    • Idarubicin Hydrochloride
    Italy

  • Study on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin
    • Paclitaxel
    Germany Italy Poland Spain

  • Study to Evaluate Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn’s Disease and an Ileostomy

    Not recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Azd7798
    Belgium Italy The Netherlands Poland Sweden

  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Niraparib
    • Dostarlimab
    Italy

  • Study of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin’s Lymphoma Eligible for Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Bendamustine Hydrochloride
    • Gemcitabine
    Italy

  • Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Inupadenant
    • Inupadenant Hydrochloride
    • Dostarlimab
    Belgium France Italy Spain

  • Study of L19IL2 and L19TNF for Patients with Skin Cancer Suitable for Direct Tumor Injection

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Skin cancer
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    France Italy Spain

  • Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Italy Norway Spain Sweden
Previous Page
1 … 45 46 47 48 49 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!